Innate Pharma (IPHA) Common Equity (2017 - 2026)
Innate Pharma (IPHA) reported Common Equity of -$47.08 million for the quarter ended Jun 30, 2026, compared with $5.82 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Common Equity (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Common Equity of -$24.52 million.
- By year, Common Equity came in at $9.56 million in the year ended Dec 31, 2024 (-83.0%), $56.14 million in the year ended Dec 31, 2023 (-1.6%), $57.07 million in the year ended Dec 31, 2022 (-53.6%) and $122.91 million in the year ended Dec 31, 2021 (-31.0%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Common Equity in data going back to the quarter ended Dec 31, 2017.
- The high point for year-over-year Common Equity in five years was the quarter ended Dec 31, 2023 (growth of 1.1%); the low point was the quarter ended Dec 31, 2024 (a decline of 83.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | -47.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.08 Mn |
| Dec 31, 2025 | -25.26 Mn |
| Jun 30, 2025 | 5.82 Mn |
| Dec 31, 2024 | 9.44 Mn |
| Jun 30, 2024 | 31.01 Mn |
| Dec 31, 2023 | 55.84 Mn |
| Jun 30, 2023 | 63.01 Mn |
| Dec 31, 2022 | 55.25 Mn |
| Jun 30, 2022 | 124.13 Mn |
| Dec 31, 2021 | 122.91 Mn |
| Jun 30, 2021 | 160.84 Mn |
| Dec 31, 2020 | 185.97 Mn |
| Jun 30, 2020 | 207.76 Mn |
| Dec 31, 2019 | 240.66 Mn |
| Dec 31, 2018 | 190.89 Mn |
| Dec 31, 2017 | 101.21 Mn |
API Access
Innate Pharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();